Scipio Bioscience
Luc Walrafen serves as the Chief Financial Officer at Scipio Bioscience since 2017. Prior to this role, Luc held positions as a Partner at Innovatys Consulting from January 2022 to September 2022, and as General Secretary at Moviken from 2012 to 2015. Luc's career includes significant experience as CFO at Qosmos (June 2011 - February 2012), and business development roles at Atos Origin and Atos Worldline, where responsibilities included fostering client innovations and developing marketing strategies. Earlier experience includes Deputy General Manager at Zandan and Investment Manager at Electra Partners Europe, focusing on LBO deals and investment opportunities. Luc holds an MBA from ESSEC Business School and has a strong educational background from prestigious institutions, including Saint Louis de Gonzague-Franklin and Lyc茅e Rochambeau.
This person is not in any teams
Scipio Bioscience
Scipio Bioscience, a Paris-based biotechnology company, provides a novel sample preparation technology for single-cell studies in the form of benchtop kits, for use prior to sequencing applications in clinical and basic research, such as transcriptomics.